Federated Hermes, Inc. Evotec Se Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$8.33 - $11.89 $13,328 - $19,024	-1,600 Reduced 0.28%	576,933 $6.77 Million
Q3 2023 Nov 13, 2023	SELL	$9.63 - $13.36 $1.65 Million - $2.29 Million	-171,467 Reduced 22.86%	578,533 $5.71 Million
Q3 2022 Nov 14, 2022	BUY	$8.4 - $28.4 $3.24 Million - $11 Million	385,888 Added 105.98%	750,000 $6.59 Million
Q2 2022 Aug 15, 2022	SELL	$10.78 - $15.5 $3.51 Million - $5.05 Million	-325,543 Reduced 47.2%	364,112 $4.36 Million
Q4 2021 Feb 14, 2022	BUY	$22.0 - $25.77 $15.2 Million - $17.8 Million	689,655 New	689,655 $16.4 Million

2.86M

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.62B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.